Cashu
Amgen's Tavneos: A Breakthrough Treatment for ANCA-Associated Vasculitis Management
3 days ago
Stocks
Health Care
amgn
AMGEN
NASDAQ: AMGN
-5.34 (-1.51%)
347.94
USD
At close at Apr 03, 20:34 UTC
Overview
Loading chart...
Key Stats
Market Cap
187.36B
Dividend Yield
0.00%
P/E Ratio
24.30
EPS
7.62
Revenue
33.42B
Avg. Volume
2.67M
About
What does AMGN do?
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.